Recent additions may not be included but will usually appear in 24 hrs or less.
Rational | Source |
---|---|
Antibacterial activity and mechanism of berberine against Streptococcus agalactiae. β
International journal of clinical and experimental pathology (Int J Clin Exp Pathol ) Vol: 8 Issue 5 Pages: 5217-23 Pub: 2015 Epub: 2015 May 1 Authors Peng L , Kang S , Yin Z , Jia R , Song X , Li L , Li Z , Zou Y , Liang X , Li L , He C , Ye G , Yin L , Shi F , Lv C , Jing B , |
|
Antibacterial activity and mechanism of berberine against Streptococcus agalactiae. β
International journal of clinical and experimental pathology (Int J Clin Exp Pathol ) Vol: 8 Issue 5 Pages: 5217-23 Pub: 2015 Epub: 2015 May 1 Authors Peng L , Kang S , Yin Z , Jia R , Song X , Li L , Li Z , Zou Y , Liang X , Li L , He C , Ye G , Yin L , Shi F , Lv C , Jing B , |
|
Antibacterial activity and mechanism of berberine against Streptococcus agalactiae. β
International journal of clinical and experimental pathology (Int J Clin Exp Pathol ) Vol: 8 Issue 5 Pages: 5217-23 Pub: 2015 Epub: 2015 May 1 Authors Peng L , Kang S , Yin Z , Jia R , Song X , Li L , Li Z , Zou Y , Liang X , Li L , He C , Ye G , Yin L , Shi F , Lv C , Jing B , |
|
Modulation of gut microbiota by berberine and metformin during the treatment of high-fat diet-induced obesity in rats. β
Go to Publication β
Scientific reports (Sci Rep ) Vol: 5 Issue Pages: 14405 Pub: 2015 Sep 23 Epub: 2015 Sep 23 Authors Zhang X , Zhao Y , Xu J , Xue Z , Zhang M , Pang X , Zhang X , Zhao L , |
|
Berberine Is a Novel Type Efflux Inhibitor Which Attenuates the MexXY-Mediated Aminoglycoside Resistance in Pseudomonas aeruginosa. β
Go to Publication β
Frontiers in microbiology (Front Microbiol ) Vol: 7 Issue Pages: 1223 Pub: 2016 Epub: 2016 Aug 5 Authors Morita Y , Nakashima K , Nishino K , Kotani K , Tomida J , Inoue M , Kawamura Y , |
|
Antibacterial in vitro effects of preparations from Anthroposophical Medicine. β
BMC complementary and alternative medicine (BMC Complement Altern Med ) Vol: 16 Issue 1 Pages: 372 Pub: 2016 Sep 22 Epub: 2016 Sep 22 Authors Roser E , Gründemann C , Engels I , Huber R , |
|
Curated database of commensal, symbiotic and pathogenic microbiota β
Generative Bioinformatics (Center of Excellence in Generative Medicine ) Vol: Issue Pages: Pub: 2014 Jun Epub: Authors D'Adamo Peter , |
|
Curated database of commensal, symbiotic and pathogenic microbiota β
Generative Bioinformatics (Center of Excellence in Generative Medicine ) Vol: Issue Pages: Pub: 2014 Jun Epub: Authors D'Adamo Peter , |
|
Curated database of commensal, symbiotic and pathogenic microbiota β
Generative Bioinformatics (Center of Excellence in Generative Medicine ) Vol: Issue Pages: Pub: 2014 Jun Epub: Authors D'Adamo Peter , |
|
Curated database of commensal, symbiotic and pathogenic microbiota β
Generative Bioinformatics (Center of Excellence in Generative Medicine ) Vol: Issue Pages: Pub: 2014 Jun Epub: Authors D'Adamo Peter , |
|
Curated database of commensal, symbiotic and pathogenic microbiota β
Generative Bioinformatics (Center of Excellence in Generative Medicine ) Vol: Issue Pages: Pub: 2014 Jun Epub: Authors D'Adamo Peter , |
|
Curated database of commensal, symbiotic and pathogenic microbiota β
Generative Bioinformatics (Center of Excellence in Generative Medicine ) Vol: Issue Pages: Pub: 2014 Jun Epub: Authors D'Adamo Peter , |
|
Berberine protects against diet-induced obesity through regulating metabolic endotoxemia and gut hormone levels. β
Go to Publication β
Molecular medicine reports (Mol Med Rep ) Vol: 15 Issue 5 Pages: 2765-2787 Pub: 2017 May Epub: 2017 Mar 14 Authors Xu JH , Liu XZ , Pan W , Zou DJ , |
|
Berberine protects against diet-induced obesity through regulating metabolic endotoxemia and gut hormone levels. β
Go to Publication β
Molecular medicine reports (Mol Med Rep ) Vol: 15 Issue 5 Pages: 2765-2787 Pub: 2017 May Epub: 2017 Mar 14 Authors Xu JH , Liu XZ , Pan W , Zou DJ , |
|
Berberine protects against diet-induced obesity through regulating metabolic endotoxemia and gut hormone levels. β
Go to Publication β
Molecular medicine reports (Mol Med Rep ) Vol: 15 Issue 5 Pages: 2765-2787 Pub: 2017 May Epub: 2017 Mar 14 Authors Xu JH , Liu XZ , Pan W , Zou DJ , |
|
Berberine protects against diet-induced obesity through regulating metabolic endotoxemia and gut hormone levels. β
Go to Publication β
Molecular medicine reports (Mol Med Rep ) Vol: 15 Issue 5 Pages: 2765-2787 Pub: 2017 May Epub: 2017 Mar 14 Authors Xu JH , Liu XZ , Pan W , Zou DJ , |
|
Berberine protects against diet-induced obesity through regulating metabolic endotoxemia and gut hormone levels. β
Go to Publication β
Molecular medicine reports (Mol Med Rep ) Vol: 15 Issue 5 Pages: 2765-2787 Pub: 2017 May Epub: 2017 Mar 14 Authors Xu JH , Liu XZ , Pan W , Zou DJ , |
|
Structural changes of gut microbiota during berberine-mediated prevention of obesity and insulin resistance in high-fat diet-fed rats. β
Go to Publication β
PloS one (PLoS One ) Vol: 7 Issue 8 Pages: e42529 Pub: 2012 Epub: 2012 Aug 3 Authors Zhang X , Zhao Y , Zhang M , Pang X , Xu J , Kang C , Li M , Zhang C , Zhang Z , Zhang Y , Li X , Ning G , Zhao L , |
|
Structural changes of gut microbiota during berberine-mediated prevention of obesity and insulin resistance in high-fat diet-fed rats. β
Go to Publication β
PloS one (PLoS One ) Vol: 7 Issue 8 Pages: e42529 Pub: 2012 Epub: 2012 Aug 3 Authors Zhang X , Zhao Y , Zhang M , Pang X , Xu J , Kang C , Li M , Zhang C , Zhang Z , Zhang Y , Li X , Ning G , Zhao L , |
|
The Effects of Berberine on the Gut Microbiota in Apc <sup>min/+</sup> Mice Fed with a High Fat Diet. β
Molecules (Basel, Switzerland) (Molecules ) Vol: 23 Issue 9 Pages: Pub: 2018 Sep 8 Epub: 2018 Sep 8 Authors Wang H , Guan L , Li J , Lai M , Wen X , |
|
Dietary prophage inducers and antimicrobials: toward landscaping the human gut microbiome. β
Go to Publication β
Gut microbes (Gut Microbes ) Vol: Issue Pages: 1-14 Pub: 2020 Jan 13 Epub: 2020 Jan 13 Authors Boling L , Cuevas DA , Grasis JA , Kang HS , Knowles B , Levi K , Maughan H , McNair K , Rojas MI , Sanchez SE , Smurthwaite C , Rohwer F , |
|
Dietary prophage inducers and antimicrobials: toward landscaping the human gut microbiome. β
Go to Publication β
Gut microbes (Gut Microbes ) Vol: Issue Pages: 1-14 Pub: 2020 Jan 13 Epub: 2020 Jan 13 Authors Boling L , Cuevas DA , Grasis JA , Kang HS , Knowles B , Levi K , Maughan H , McNair K , Rojas MI , Sanchez SE , Smurthwaite C , Rohwer F , |
|
Effect of Berberine on Atherosclerosis and Gut Microbiota Modulation and Their Correlation in High-Fat Diet-Fed ApoE-/- Mice. β
Go to Publication β
Frontiers in pharmacology (Front Pharmacol ) Vol: 11 Issue Pages: 223 Pub: 2020 Epub: 2020 Mar 13 Authors Wu M , Yang S , Wang S , Cao Y , Zhao R , Li X , Xing Y , Liu L , |
|
Effect of Berberine on Atherosclerosis and Gut Microbiota Modulation and Their Correlation in High-Fat Diet-Fed ApoE-/- Mice. β
Go to Publication β
Frontiers in pharmacology (Front Pharmacol ) Vol: 11 Issue Pages: 223 Pub: 2020 Epub: 2020 Mar 13 Authors Wu M , Yang S , Wang S , Cao Y , Zhao R , Li X , Xing Y , Liu L , |
|
Modulation of gut microbiota mediates berberine-induced expansion of immuno-suppressive cells to against alcoholic liver disease. β
Go to Publication β
Clinical and translational medicine (Clin Transl Med ) Vol: 10 Issue 4 Pages: e112 Pub: 2020 Aug Epub: 2020 Aug 13 Authors Li S , Wang N , Tan HY , Chueng F , Zhang ZJ , Yuen MF , Feng Y , |
|
Modulation of gut microbiota mediates berberine-induced expansion of immuno-suppressive cells to against alcoholic liver disease. β
Go to Publication β
Clinical and translational medicine (Clin Transl Med ) Vol: 10 Issue 4 Pages: e112 Pub: 2020 Aug Epub: 2020 Aug 13 Authors Li S , Wang N , Tan HY , Chueng F , Zhang ZJ , Yuen MF , Feng Y , |
|
Berberine attenuates choline-induced atherosclerosis by inhibiting trimethylamine and trimethylamine-N-oxide production via manipulating the gut microbiome. β
Go to Publication β
NPJ biofilms and microbiomes (NPJ Biofilms Microbiomes ) Vol: 7 Issue 1 Pages: 36 Pub: 2021 Apr 16 Epub: 2021 Apr 16 Authors Li X , Su C , Jiang Z , Yang Y , Zhang Y , Yang M , Zhang X , Du Y , Zhang J , Wang L , Jiang J , Hong B , |
|
A Holistic View of Berberine Inhibiting Intestinal Carcinogenesis in Conventional Mice Based on Microbiome-Metabolomics Analysis. β
Go to Publication β
Frontiers in immunology (Front Immunol ) Vol: 11 Issue Pages: 588079 Pub: 2020 Epub: 2020 Sep 24 Authors Chen H , Zhang F , Zhang J , Zhang X , Guo Y , Yao Q , |
|
Berberine ameliorates aGVHD by gut microbiota remodelling, TLR4 signalling suppression and colonic barrier repairment for NLRP3 inflammasome inhibition. β
Go to Publication β
Journal of cellular and molecular medicine (J Cell Mol Med ) Vol: 26 Issue 4 Pages: 1060-1070 Pub: 2022 Feb Epub: 2022 Jan 5 Authors Zhao Y , Huang J , Li T , Zhang S , Wen C , Wang L , |
|
Effectiveness and safety of Bifidobacterium and berberine in human hyperglycemia and their regulatory effect on the gut microbiota: a multi-center, double-blind, randomized, parallel-controlled study. β
Go to Publication β
Genome medicine (Genome Med ) Vol: 13 Issue 1 Pages: 125 Pub: 2021 Aug 9 Epub: 2021 Aug 9 Authors Ming J , Yu X , Xu X , Wang L , Ding C , Wang Z , Xie X , Li S , Yang W , Luo S , He Q , Du Y , Tian Z , Gao X , Ma K , Fang Y , Li C , Zhao J , Wang X , Ji Q , |
|
Synergy-directed fractionation of botanical medicines: a case study with goldenseal (Hydrastis canadensis). β
Go to Publication β
Journal of natural products (J Nat Prod ) Vol: 74 Issue 7 Pages: 1621-9 Pub: 2011 Jul 22 Epub: 2011 Jun 10 Authors Junio HA , Sy-Cordero AA , Ettefagh KA , Burns JT , Micko KT , Graf TN , Richter SJ , Cannon RE , Oberlies NH , Cech NB , |
|
Goldenseal (Hydrastis canadensis L.) extracts synergistically enhance the antibacterial activity of berberine via efflux pump inhibition. β
Go to Publication β
Planta medica (Planta Med ) Vol: 77 Issue 8 Pages: 835-40 Pub: 2011 May Epub: 2010 Dec 14 Authors Ettefagh KA , Burns JT , Junio HA , Kaatz GW , Cech NB , |
|
Antibacterial activity of Hydrastis canadensis extract and its major isolated alkaloids. β
Planta medica (Planta Med ) Vol: 67 Issue 6 Pages: 561-4 Pub: 2001 Aug Epub: Authors Scazzocchio F , Cometa MF , Tomassini L , Palmery M , |
|
Antibacterial activity of Hydrastis canadensis extract and its major isolated alkaloids. β
Planta medica (Planta Med ) Vol: 67 Issue 6 Pages: 561-4 Pub: 2001 Aug Epub: Authors Scazzocchio F , Cometa MF , Tomassini L , Palmery M , |
|
Antibacterial activity of Hydrastis canadensis extract and its major isolated alkaloids. β
Planta medica (Planta Med ) Vol: 67 Issue 6 Pages: 561-4 Pub: 2001 Aug Epub: Authors Scazzocchio F , Cometa MF , Tomassini L , Palmery M , |
|
Antibacterial activity of Hydrastis canadensis extract and its major isolated alkaloids. β
Planta medica (Planta Med ) Vol: 67 Issue 6 Pages: 561-4 Pub: 2001 Aug Epub: Authors Scazzocchio F , Cometa MF , Tomassini L , Palmery M , |
|
Antibacterial activity of Hydrastis canadensis extract and its major isolated alkaloids. β
Planta medica (Planta Med ) Vol: 67 Issue 6 Pages: 561-4 Pub: 2001 Aug Epub: Authors Scazzocchio F , Cometa MF , Tomassini L , Palmery M , |
|
Secondary Metabolites from the Leaves of the Medicinal Plant Goldenseal (Hydrastis canadensis). β
Go to Publication β
Phytochemistry letters (Phytochem Lett ) Vol: 20 Issue Pages: 54-60 Pub: 2017 Jun Epub: 2017 Apr 15 Authors Leyte-Lugo M , Britton ER , Foil DH , Brown AR , Todd DA , Rivera-Chávez J , Oberlies NH , Cech NB , |
|
Biochemometrics to Identify Synergists and Additives from Botanical Medicines: A Case Study with Hydrastis canadensis (Goldenseal). β
Go to Publication β
Journal of natural products (J Nat Prod ) Vol: 81 Issue 3 Pages: 484-493 Pub: 2018 Mar 23 Epub: 2017 Nov 1 Authors Britton ER , Kellogg JJ , Kvalheim OM , Cech NB , |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]